| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8234985 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 7 Pages |
Abstract
Low pretreatment testosterone levels alone did not affect disease recurrence or OS. Patients with baseline low testosterone who also were treated with ADT had a trend toward decreased OS.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Al V. M.D., Gregory S. M.D., Robert W. Ph.D., Wayne M. Ph.D., Kent E. M.D., Zachariah A. M.S., Jonathan H. Ph.D., Edward M.D.,